Development of Extemporaneous Compounding as an Initiating Factor in the Transformation of Pharmaceutical Education: International Experience and Current Trends
INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to en...
Saved in:
Published in: | Regulatory Research and Medicine Evaluation Vol. 14; no. 4; pp. 419 - 436 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
01-09-2024
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.
AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.
MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.
RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.
CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency. |
---|---|
AbstractList | INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.
AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.
MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.
RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.
CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency. INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency. |
Author | Bykov, A. V. Korol, L. A. Egorova, S. N. Sadkovskii, I. A. Mandrik, M. A. Krasnyuk, I. I. |
Author_xml | – sequence: 1 givenname: M. A. orcidid: 0000-0002-3558-9615 surname: Mandrik fullname: Mandrik, M. A. organization: I.M. Sechenov First Moscow State Medical University (Sechenov University) – sequence: 2 givenname: I. A. orcidid: 0000-0001-8375-9909 surname: Sadkovskii fullname: Sadkovskii, I. A. organization: I.M. Sechenov First Moscow State Medical University (Sechenov University) – sequence: 3 givenname: L. A. orcidid: 0000-0001-5919-1866 surname: Korol fullname: Korol, L. A. organization: I.M. Sechenov First Moscow State Medical University (Sechenov University) – sequence: 4 givenname: S. N. orcidid: 0000-0001-7671-3179 surname: Egorova fullname: Egorova, S. N. organization: Kazan State Medical University – sequence: 5 givenname: I. I. orcidid: 0000-0002-7242-2988 surname: Krasnyuk fullname: Krasnyuk, I. I. organization: I.M. Sechenov First Moscow State Medical University (Sechenov University) – sequence: 6 givenname: A. V. surname: Bykov fullname: Bykov, A. V. organization: R-Pharm |
BookMark | eNo9kd1uVCEUhYmpibX2Hbjw9ih_5wfjjRmnOkmTejFekw1sWswMTOAcU9_GRy1nqs1OgLVX9gdkvSUXKSck5D1nHySbdP-Ra807obnuBBOq46pr1ZSSwytyKZlUnVS9vPh_ZoN4Q65rjZb1I58UH_Ul-fsVf-Mhn46YZpoD3T7OeDzlAgnzUukmN7EkH9M9hUoh0V2Kc4R5bdyAm3OhMdH5Aem-zdSQy7GZOa2sHw_QlMNljg4OdOsXd_Y-NciMJZ3FajyesERMDtsFnm6WUtbX7Nvq6zvyOsCh4vW__Yr8vNnuN9-727tvu82X285xrvtu5KjRS49q8iLACHxyvQ5ikMyK5oEaHB-BKWshSOthUtoOVrY-AxekvCK7Z67P8MucSjxC-WMyRHNu5HJvoLSPHNA4ba2SgTMlQuNZDWKUkw1TP7kJ-r6xPj-zXMm1FgwvPM7MOTyzhmfW8MwanuHKtGqqhSefAAjAlDc |
Cites_doi | 10.1093/ijpp/riac062 10.1080/15602210500282517 10.1016/j.ajpe.2023.100116 10.5688/ajpe8617 10.1016/j.ajpe.2023.100571 10.26442/00403660.2022.08.201805 10.47093/2713-069X.2021.2.1.12-20 10.1186/s40545-023-00520-9 10.3390/children10010147 10.3390/pharmacy8030117 10.1016/j.cptl.2019.12.016 10.5688/ajpe81464 10.18288/1994-5124-2018-2-04 10.5688/ajpe768146 10.1186/s40545-023-00618-0 10.1016/j.cptl.2019.11.013 10.33920/med-13-2006-02 10.19163/2307-9266-2023-11-2-161-172 10.1016/j.cptl.2023.06.012 10.29060/TAPS.2018-3-1/OA1048 10.1136/ejhpharm-2019-001891 10.1016/j.ajpe.2023.100117 10.19163/2307-9266-2023-11-3-176-192 10.15829/1728-8800-2022-3481 10.5688/ajpe7394 10.5688/ajpe8345 |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.30895/1991-2919-2024-14-4-419-436 |
DatabaseName | CrossRef Open Access: DOAJ - Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 3034-3453 |
EndPage | 436 |
ExternalDocumentID | oai_doaj_org_article_c9bb43f1042f4bbb9a2738bf858c8a55 10_30895_1991_2919_2024_14_4_419_436 |
GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION GROUPED_DOAJ |
ID | FETCH-LOGICAL-c1195-71e9ed3de48d2fa7a18c59f2630b21e9a46c17a04bbaf3bda849b6b3a460acf33 |
IEDL.DBID | DOA |
ISSN | 3034-3062 |
IngestDate | Mon Nov 11 19:40:06 EST 2024 Fri Nov 22 01:29:53 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 4 |
Language | English Russian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1195-71e9ed3de48d2fa7a18c59f2630b21e9a46c17a04bbaf3bda849b6b3a460acf33 |
ORCID | 0000-0002-3558-9615 0000-0001-5919-1866 0000-0002-7242-2988 0000-0001-8375-9909 0000-0001-7671-3179 |
OpenAccessLink | https://doaj.org/article/c9bb43f1042f4bbb9a2738bf858c8a55 |
PageCount | 18 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c9bb43f1042f4bbb9a2738bf858c8a55 crossref_primary_10_30895_1991_2919_2024_14_4_419_436 |
PublicationCentury | 2000 |
PublicationDate | 2024-09-01 |
PublicationDateYYYYMMDD | 2024-09-01 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Regulatory Research and Medicine Evaluation |
PublicationYear | 2024 |
Publisher | Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) |
Publisher_xml | – name: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) |
References | ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref27 doi: 10.1093/ijpp/riac062 – ident: ref1 – ident: ref15 doi: 10.1080/15602210500282517 – ident: ref7 – ident: ref29 doi: 10.1016/j.ajpe.2023.100116 – ident: ref25 – ident: ref31 doi: 10.5688/ajpe8617 – ident: ref28 doi: 10.1016/j.ajpe.2023.100571 – ident: ref2 doi: 10.26442/00403660.2022.08.201805 – ident: ref8 doi: 10.47093/2713-069X.2021.2.1.12-20 – ident: ref14 doi: 10.1186/s40545-023-00520-9 – ident: ref13 doi: 10.3390/children10010147 – ident: ref11 – ident: ref17 doi: 10.3390/pharmacy8030117 – ident: ref6 – ident: ref22 doi: 10.1016/j.cptl.2019.12.016 – ident: ref24 doi: 10.5688/ajpe81464 – ident: ref4 doi: 10.18288/1994-5124-2018-2-04 – ident: ref19 doi: 10.5688/ajpe768146 – ident: ref32 doi: 10.1186/s40545-023-00618-0 – ident: ref21 – ident: ref23 doi: 10.1016/j.cptl.2019.11.013 – ident: ref10 doi: 10.33920/med-13-2006-02 – ident: ref5 doi: 10.19163/2307-9266-2023-11-2-161-172 – ident: ref33 doi: 10.1016/j.cptl.2023.06.012 – ident: ref18 doi: 10.29060/TAPS.2018-3-1/OA1048 – ident: ref20 doi: 10.1136/ejhpharm-2019-001891 – ident: ref12 doi: 10.1016/j.ajpe.2023.100117 – ident: ref3 doi: 10.19163/2307-9266-2023-11-3-176-192 – ident: ref9 doi: 10.15829/1728-8800-2022-3481 – ident: ref16 – ident: ref26 doi: 10.5688/ajpe7394 – ident: ref30 doi: 10.5688/ajpe8345 |
SSID | ssib057184179 ssib056345391 ssib057142307 |
Score | 1.9336404 |
Snippet | INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical... |
SourceID | doaj crossref |
SourceType | Open Website Aggregation Database |
StartPage | 419 |
SubjectTerms | accreditation compounding pharmacies extemporaneous compounding international experience licensing of pharmaceutical workers pharmaceutical education pharmacy technician |
Title | Development of Extemporaneous Compounding as an Initiating Factor in the Transformation of Pharmaceutical Education: International Experience and Current Trends |
URI | https://doaj.org/article/c9bb43f1042f4bbb9a2738bf858c8a55 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB8QFFZWKQovm0KvVxN_m1pZdlQuqRJF6i_wpuGRRy0r8HH4qM07YDScuKCcnSiL7vcgz9ssbxs5llKHEbHjxRnFVUuRR-sxtVdLpVJNqYsybz_bTvfuwIpucXakv0oRN9sDTwF0kH6OSFbMGUVWM0Qf6mSRWp11yQU_upZ1ZJFPIJG2k0nLvAqNtr8TC-ArbjkpvUQmzTtLWgBHP2DmlsJ3z-qLpgYTvPZJIKN5jL2i7lKvm5LyfvxY2_20-Wh-yF3MgCZdTB16yJw_bI_ZroQGCTYXVz9l6aiyY4QN9_FRGCacrCI8QRvhI2qFA0mdYt8o78G0EjAnhbhHQbkZ61u3X5eo37JQh7-GvVUXYmyfjCzLMBlAwiW9fsS_r1d31DZ9rMPBEZnDc9sWXLHNRLosabOhd0r4KI7so8FpQJvU2dAhNqDLm4JSPBgmgTBdSlfKYHYybsbxmYFLGeCLbVASmJcJGn6StpTalVbT9CdN_Rnb4PlltDJiiNEQGQmQgRAZCBBOWAQ9sISIn7Ipg2N1DhtntBNJomGk0_ItGb_7HQ96y540vTYJ2yg5-PGzLGXv6mLfvGj1_A8jc5ho |
link.rule.ids | 315,782,786,866,2106,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Extemporaneous+Compounding+as+an+Initiating+Factor+in+the+Transformation+of+Pharmaceutical+Education%3A+International+Experience+and+Current+Trends&rft.jtitle=Regulatory+Research+and+Medicine+Evaluation&rft.au=Mandrik%2C+M.+A.&rft.au=Sadkovskii%2C+I.+A.&rft.au=Korol%2C+L.+A.&rft.au=Egorova%2C+S.+N.&rft.date=2024-09-01&rft.issn=3034-3062&rft.eissn=3034-3453&rft.volume=14&rft.issue=4&rft.spage=419&rft.epage=436&rft_id=info:doi/10.30895%2F1991-2919-2024-14-4-419-436&rft.externalDBID=n%2Fa&rft.externalDocID=10_30895_1991_2919_2024_14_4_419_436 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=3034-3062&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=3034-3062&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=3034-3062&client=summon |